期刊文献+

慢性充血性心力衰竭病人血浆中叶素的变化及意义 被引量:2

Plasma Intermedin Concentration in Patients with Chronic Heart Faliure
下载PDF
导出
摘要 目的:探讨中叶素在慢性充血性心力衰竭(CHF)患者血浆中的变化。方法:放射免疫分析42例健康体检者和46例CHF患者血浆中叶素、脑钠素(BNP)和C反应蛋白(CRP)水平。结果:与正常健康人比较,CHF患者血浆中叶素含量降低53.2%(P<0.01);CHF患者血浆BNP和CRP水平分别增加1658.5%和80.5%(P<0.001)。与心功能Ⅰ-Ⅱ级病人比较,心功能Ⅲ-Ⅳ级病人血浆中叶素较心功能Ⅰ-Ⅱ级病人降低34.7%(P<0.05);心功能Ⅲ-Ⅳ级病人血浆中BNP和CRP含量分别增加257.8%和76%(P<0.001)。结论:CHF病人血浆BNP和CRP在CHF患者中显著增加,其幅度与病情的严重性相一致。CHF患者血浆中叶素浓度的降低与CHF的严重程度相关,血浆中叶素减少可能与CHF的进一步恶化有重要的关系。 Objective To study the clinical significance of determination of changes of plasma levels of intermedin(IMD),BNP and CRP in patients with chronic heart failure.Methods Plasma IMD,BNP(with RIA) and CRP(with immuno-turbidity) levels were determined in 46 patients with chronic heart failure of various grades(grade Ⅰ-Ⅱ n=31,grade Ⅲ-Ⅳ,n=15) and 42 normal controls. Results Compared with the control group,the plasma IMD level in patients with chronic heart failure was decreased 53.2%(P0.01),the BNP and CRP were increased 1658.5% and 80.5% respectively(each P0.001).Compared with the grade Ⅰ-Ⅱ group,the plasma IMD level in grade Ⅲ-Ⅳ was decreased 34.7%(P0.05),the BNP and CRP levels in grade Ⅲ-Ⅳ were increased 257.8% and 76%(all P0.001) individually.Conclusion Plasma intermedin concentration was significantly decreased in patients with chronic heart failure,which suggests that they play an important role in the pathogenesis of chronic heart failure.
出处 《放射免疫学杂志》 CAS 2011年第5期488-490,共3页 Journal of Radioimmanology
关键词 慢性充血性 心力衰竭 中叶素 脑钠素 C反应蛋白 chronic heart failure(CHF) intermedin(IMD) BNP CRP
  • 相关文献

参考文献17

  • 1Roh J,Chang CL,Bhalla A,et al.Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes[J].J Biol Chem,2004,279(8):7264-7274.
  • 2Takei Y,Inoue K,Ogoshi M,et al.Identification of novel adrenomedullin in mammals:a potent cardiovascular and renal regulator[J].FEBS Lett,2004,556(1-3):53-58.
  • 3Takahashi K,Kikuchi K,Maruyama Y,et al.Immunocytochemical localization of adrenomedullin 2/intermedin-like immunoreactivity in human hypothalamus,heart and kidney[J].Peptides,2006,27(6):1383-1389.
  • 4Morimoto R,Satoh F,Murakami O,et al.Expression of adrenomedullin2/intermedin in human brain,heart,and kidney[J].Peptides,2007,28(5):1095-1103.
  • 5Bell D,McDermott BJ.Intermedin (adrenomedullin-2):a novel counter-regulatory peptide in the cardiovascular and renal systems[J].Br J Pharmacol,2008,153(Suppl 1):S247-262.
  • 6Yang JH,Ma CG,Cai Y,et al.Effect of intermedin1-53 on angiotensin Ⅱ-induced hypertrophy in neonatal rat ventricular myocytes[J].J Cardiovasc Pharmacol,2010,56(1):45-52.
  • 7Fujisawa Y,Nagai Y,Miyatake A,et al.Effects of adrenomedullin 2 on regional hemodynamics in conscious rats[J].Eur J Pharmacol,2007,558(1-3):128-132.
  • 8Yang JH,Qi YF,Jia YX,et al.Protective effects of intermedin/adrenomedullin2 on ischemia/reperfusion injury in isolated rat hearts[J].Peptides,2005,26 (3):501-507.
  • 9Yang JH,Jia YX,Pan CS,et al.Effects of intermedin1-53 on cardiac function and ischemia/reperfusion injury in isolated rat hearts[J].Biochem Biophys Res Commun 2005,327:713-719.
  • 10Hagiwara M,Bledsoe G,Yang ZR,et al.Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress[J].Am J Physiol Renal Physiol,2008,295(6):F1735-1743.

同被引文献29

  • 1王学军,朱艳霞,肖敏,张绪国,任永生.慢性心力衰竭患者血浆中介素与一氧化氮相关性研究[J].湖北医药学院学报,2011,30(5):487-490. 被引量:2
  • 2杨靖辉,贾月霞,任永生,唐朝枢.中叶素1-53对大鼠动脉血压的影响及其作用机制[J].高血压杂志,2005,13(11):711-715. 被引量:11
  • 3Biondi B,Palmieri EA,Fazio S. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-age patients[J].Journal of Clinical Endocrinology and Metabolism,2000,(12):4701-4705.
  • 4Irwin Klein,Sara Danzi. Thyroid disease and the heart[J].Circulation,2007,(15):1725-1735.
  • 5Takei Y,Inoue K,Ogoshi M. Identification of novel adrenomedullin in mammals:a potent cardiovascular and renal regulator[J].FEBS Letters,2004,(1-3):53-58.
  • 6Bell D,McDermott BJ. Intermedin(adrenomedullin-2):a novel counter-regulatory peptide in the cardiovascular and renal systems[J].British Journal of Pharmacology,2008,(Suppl 1):S247-S262.
  • 7Yang JH,Qi YF,Jia YX. Protective effects of intermedin/adrenomedullin2 on ischemia/reperfusion injury in isolated rat hearts[J].Peptides,2005,(03):501-507.
  • 8Pearson LJ,Yandle TG,Nicholls MG. Intermedin(adrenomedullin-2):a potential protective role in human aortic endothelial cells[J].Cellular Physiology and Biochemistry,2009,(1-3):97-108.
  • 9何浩明;姜建平;秦建萍.现代检验医学与临床[M]上海:同济大学出版社,2001150-151.
  • 10范小芳,田丽鲜,毛孙忠,张丽,黄萍,龚永生.高脂血症性脂肪性肝病大鼠肝脏Intermedin的表达[J].胃肠病学和肝病学杂志,2008,17(6):489-491. 被引量:7

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部